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Abstract
‘Ene’-reductases have attracted significant attention for the preparation of chemical intermediates and biologically active
products. To date, research has been focussed primarily on Old Yellow Enzyme-like proteins, due to their ease of handling,
whereas 2-enoate reductases from clostridia have received much less attention, because of their oxygen sensitivity and a
lack of suitable expression systems. A hypothetical 2-enoate reductase gene, fldZ, was identified in Clostridium sporogenes
DSM 795. The encoded protein shares a high degree of homology to clostridial FMN- and FAD-dependent 2-enoate
reductases, including the cinnamic acid reductase proposed to be involved in amino acid metabolism in proteolytic clostridia.
The gene was cloned and overexpressed in Escherichia coli. Successful expression depended on the use of strictly anaerobic
conditions for both growth and enzyme preparation, since FldZ was oxygen-sensitive. The enzyme reduced aromatic enoates,
such as cinnamic acid or p-coumaric acid, but not short chain unsaturated aliphatic acids. The b,b-disubstituted nitroalkene,
(E)-1-nitro-2-phenylpropene, was reduced to enantiopure (R)-1-nitro-2-phenylpropane with a yield of 90%. By contrast, the
a,b-disubstituted nitroalkene, (E)-2-nitro-1-phenylpropene, was reduced with a moderate yield of 56% and poor
enantioselectivity (16% ee for (S)-2-nitro-1-phenylpropane). The availability of an expression system for this recombinant
clostridial 2-enoate reductase will facilitate future characterisation of this unusual class of ‘ene’-reductases, and expand the
biocatalytic toolbox available for enantioselective hydrogenation of carbon-carbon double bonds.
INTRODUCTION
‘Ene’-reductases are being used increasingly in the phar-
maceutical and agrochemical industries to produce chiral
intermediates, pharmaceuticals and agrochemicals, since
hydrogenation of carbon-carbon double bonds in acti-
vated, prochiral alkenes can introduce up to two new
asymmetric centres in the product [1, 2]. The most widely
used enzymes are flavoprotein oxidoreductases (‘Old Yel-
low Enzyme’-like proteins; OYEs), which accept a,b-
unsaturated enals and enones as well as nitroalkenes [3].
Attempts have been made to obtain ‘ene’ reductases with
broader substrate range and enantiocomplementarity by
random and rational mutagenesis of classical OYE-like
families [4]. Enzymes such as pentaerythritol tetranitrate
reductase (PETNR) from Enterobacter cloacae, Old Yellow
Enzyme-1 (OYE1) from Saccharomyces pastorianus,
12-oxophytodienoate reductase (OPR1) from Lycopersicon
esculentum and nicotinamide-dependent cyclohexanone
reductase (NCR) from Zymomonas mobilis have been
engineered to alter their substrate ranges, improve activi-
ties and change stereoselectivities [4]. However, classical
and engineered OYEs do not accept a,b-unsaturated free
carboxylic groups or esters as substrates or these com-
pounds are reduced poorly [3, 5]. Recently, a new method
for synthesis of chiral a-substituted carboxylic acids from
a-substituted a,b-unsaturated aldehydes was exemplified
by employing biocatalytic hydrogen-borrowing enzyme
cascades [3, 6]. However, development of such reactions is
challenging, since both enzymes in the cascade must work
concomitantly and under the same reaction conditions.
Therefore, it would be desirable to identify enzymes that
can reduce the enoates directly.
Relatively little attention has been paid to 2-enoate reduc-
tases from clostridia and other strict anaerobes [7, 8],
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because these enzymes are oxygen sensitive [9] and are con-
sidered difficult to work with [10]. However, 2-enoate
reductases have broad substrate specificities and excellent
stereospecificity for carbon-carbon double bond reduction
within a,b-unsaturated carboxylates [11, 12]. Furthermore,
a diverse range of 2-enoate reductases are available, since
they are found in various proteolytic and non-proteolytic
species such as Clostridium kluyveri, Clostridium tyrobutyri-
cum, Clostridium sporogenes, and even in non-clostridial
species, such asMoorella thermoacetica and Peptostreptococ-
cus anaerobius [13–18]. The 2-enoate reductases from
C. tyrobutyricum and M. thermoacetica show partial homol-
ogy to a family of flavoproteins including enzymes such as
2,4-dienoyl-coenzyme A reductase from E. coli and OYEs
from yeasts [18]. However, unlike classical OYEs, which
have subunits with molecular weights of approximately
45 kDa, the 2-enoate reductases from C. kluyveri, M. ther-
moacetica and C. tyrobutyricum have subunit molecular
weights of approximately 73 kDa. Furthermore, these
enzymes contain flavin mononucleotide (FMN), like OYEs,
but also possess an extra flavin adenine dinucleotide (FAD)
and an iron-sulphur cluster [14, 18, 19].
Previously, we discovered that crude cell-free extracts of
C. sporogenes DSM 795 catalyse highly enantioselective
reduction of b,b-disubstituted nitroalkenes [20]. Thus, aryl
derivatives were reduced in good yields (35–86%), forming
the respective (R)-nitroalkanes with almost perfect enantio-
meric excess (ee). By contrast, a,b-disubstituted nitroal-
kenes were poor substrates, yielding the respective
(S)-nitroalkanes in low yield (10–20%) and with poor enan-
tioselectivity (30–70%). A new asymmetric methodology
was proposed for preparation of g-amino butyric acid
(GABA) derivatives, which can be used to treat a range of
central nervous system diseases [21]. The key step was the
use of crude extracts of C. sporogenes for asymmetric reduc-
tion of (Z)-3-(4-chlorophenyl)-3-cyanopropenoic acid to
(S)-3-(4-chlorophenyl)-3-cyanopropanoic acid, which was
then used to synthesize the (S)-enantiomer of baclofen.
Future exploitation or engineering of clostridial 2-enoate
reductases would depend on successful expression in a non-
clostridial host, to avoid the need for strict anaerobiosis.
Although a number of clostridial 2-enoate reductases [14,
15, 19] have been purified and characterised in vitro, none
of the enzymes from proteolytic species has been success-
fully produced in E. coli by recombinant means. However,
E. coli has been used to produce recombinant enzyme from
M. thermoacetica under anaerobic conditions [18] and an 2-
enoate reductase gene from C. acetobutylicum has been used
in a heterologous metabolic pathway for production of
hydrocinnamic acids aerobically, although the activity of the
recombinant product was improved under anaerobic condi-
tions [5]. Therefore, we identified the gene encoding
2-enoate reductase in C. sporogenes DSM 795, and demon-
strated its successful expression in anaerobically grown
E. coli. Using the recombinant protein produced, we dem-
onstrated that this enzyme is indeed responsible for the
enantioselective reduction of 2-enoates and nitroalkenes.
The availability of a recombinant 2-enoate reductase will
enable broader exploration of the potential industrial uses
of this unusual enzyme.
METHODS
Materials
Oligonucleotides and the synthetic DNA encoding C. sporo-
genes DSM 795 FldZ codon optimised for expression in
E. coli were synthesised by Eurofins Genetic Service
(Germany). Substrates and products of biotransformations
were purchased from Sigma-Aldrich representing the high-
est purity grades available, with the exception of (E)-1-
nitro-2-phenylpropene and (E)-2-nitro-1-phenylpropene
and the corresponding racemic products, 1-nitro-2-phenyl-
propane and 2-nitro-1-phenylpropane, which were synthes-
ised as described previously [20]. Media and media
components were obtained from Melford (UK) and molecu-
lar biology reagents were from Qiagen (Germany) except
where stated.
Organisms and growth
Clostridium sporogenes DSM 795 was obtained from DSMZ
(Deutsche Sammlung von Mikroorganismen und Zellkultu-
ren GmbH, Germany). E. coli JM107 was purchased from
Thermo Fisher Scientific (UK). E. coli BL21(DE3)pLysS
competent cells were obtained from Merck Millipore (UK).
C. sporogenes DSM 795 was cultivated in a medium contain-
ing cooked meat medium (5 g l 1; Lab M Limited), KH2PO4
(5 g l 1), L-cysteine HCl (0.5 g l 1), and resazurin
(0.001%w/v), with the addition of agar (20 g l 1) when
required [20]. E. coli strains JM107 and BL21(DE3)pLysS
were cultivated in LB agar or broth, adding 1% glucose for
BL21(DE3)pLysS only. Terrific Broth (TB) contained tryp-
tone (12 g), yeast extract (24 g) and glycerol (4ml) in 0.9 l of
deionized water. The medium was autoclaved, cooled to
room temperature and supplemented with phosphate
buffer/glucose solution (100ml, filter sterilised, containing
glucose, 10 g, KH2PO4, 2.31 g and K2HPO4, 12.54 g). Anaer-
obic media were prepared and sterilized as described previ-
ously [22] and then transferred to a MACS anaerobic
workstation (Don Whitley Scientific Limited), before inocu-
lation, growth and storage.
Genomic DNA extraction
An overnight culture of C. sporogenes (10ml) was centri-
fuged at 3000 g for 10min and the supernatant was
discarded. The pellet was resuspended in PBS-lysozyme lysis
buffer (180 µl; containing NaCl, 8 g l 1; KCl, 0.2 g l 1;
Na2HPO4, 1.44 g l
 1; KH2PO4, 0.24 g l
 1; lysozyme, 10 g l 1)
and incubated at 37

C for 30min, with occasional gentle agi-
tation. RNase A solution (4 µl; 10mgml 1) was added and
the sample was incubated at 37

C for 15min. Proteinase K
solution (25 µl; >600mAUml 1), deionised water (85 µl)
and sodium dodecyl sulphate solution (110 µl; 10%w/v)
were added. The sample was mixed by inversion and incu-
bated at 65

C for 30min with occasional gentle agitation.
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Phenol:chloroform:isoamyl alcohol solution (25 : 24 : 1, satu-
rated with 10mM Tris, pH 8.0, 1mM EDTA; Sigma) was
added (400 µl) and mixed thoroughly by inversion. The sam-
ple was transferred to a phase-lock tube (phase-lock gel
heavy 2.0ml, Eppendorf), mixed, and centrifuged at 12 000 g
for 3min. The top layer was transferred into a fresh phase-
lock tube and the phenol:chloroform:isoamyl alcohol extrac-
tion was repeated twice more. The top layer was transferred
into a 1.5ml microcentrifuge tube containing 3 M sodium
acetate solution pH 5.2 (40 µl) and ice cold absolute ethanol
(800 µl). The mixture was mixed gently but thoroughly and
incubated at  80

C for 30min. The sample was centrifuged
at 12 000 g for 15min and the supernatant was poured off
quickly to avoid resuspension of the pellet. The sample was
washed by adding ethanol solution (1ml; 70% v/v) and cen-
trifuged at 12 000 g for 3min. The supernatant was poured
off quickly and the DNA pellet was air dried for 45min at
room temperature. The pellet was dissolved in 50 µl of EB
buffer (Qiagen).
Cloning of fldZ reductase gene
Cloning was performed using standard molecular biology
techniques. PCR was performed with FailSafe PCR System
(Epicentre) using the C. sporogenes genomic DNA as a tem-
plate with primers PM003 (5¢-GGATGTACTACAAGTGC
TATTCAC-3¢) and PM008 (5¢-AGTGCTGGATTTAGTC
TAC-3¢). The PCR product was cloned into pJET1.2
(Thermo Fisher Scientific) and sequenced. For protein over-
expression, the fldZ gene was codon optimised for expres-
sion in E. coli with GENEius software (Eurofins MWG
Operon) and synthesised with NdeI (at the 5¢-end) and NotI
(at the 3’-end) restriction sites. After restriction digestion
with NdeI and NotI (Thermo Fisher Scientic) the insert
from the cloning vector was ligated into pET20b(+) cut with
the same restriction enzymes, to form the plasmid pET20b
(+):CsfldZ. Cloning of other expression plasmids is
described in the Supplementary information 3.
Protein overexpression in E. coli under anaerobic
conditions
Expression of fldZ was analysed in anaerobic cultures of
E. coli BL21(DE3)pLysS. The strain carrying pET20b(+):
CsfldZ was grown aerobically in LB supplemented with car-
benicillin (50 µgml 1) and chloramphenicol (34 µgml 1).
The culture was stored at  80

C after adding 0.2 g glycerol
per ml of culture. Pre-cultures were inoculated directly from
the cryostock and were grown aerobically overnight in LB
(10ml) with the antibiotics and 1% glucose at 37

C with
shaking at 200 r.p.m. Aliquots of the pre-cultures (100–
500 µl) were used to inoculate the same medium (20ml) in
a sterile 50ml plastic centrifuge tube and the cultures were
incubated at 37

C for about 6–7 h with shaking at
200 r.p.m. until the OD600 reached 0.9–1 (UVmini 1240
spectrophotometer, Shimadzu) and were kept at 4

C over-
night. The following day, the cells were collected by
centrifuging at 3000 g for 10min at 4

C. The supernatant
was discarded and the pellet was transferred into the anaer-
obic workstation. The pellets were used to inoculate
anaerobic TB medium (100ml) supplemented with antibi-
otics, glucose (final concentration 10 g l 1) and riboflavin
(1 µgml 1, filter sterilized) in a Duran screw cap bottle
(100ml) containing a magnetic flea. Cultures were mixed
using a magnetic stirrer at 100 r.p.m. at 30

C. When the
OD600 reached 0.4–0.5, expression of proteins was induced
by adding filter sterilized 1M isopropyl b-D-1-thiogalacto-
pyranoside (40 µl). Samples (2ml) were taken before induc-
tion and at intervals after induction in order to determine
the time point giving the highest protein yield. The cells
were harvested by centrifugation at 3000 g for 10min at 4

C
in the anaerobic workstation. Pellets were resuspended in
anaerobic lysis buffer (250 µlml 1 of the culture). The lysis
buffer contained flavin adenine dinucleotide (0.1 µmol),
riboflavin-5-phosphate (0.1 µmol), Benzonase Nuclease
(1 µl; 250 U; Sigma), 10 BugBuster Protein Extraction
Reagent (1ml; Merck) and complete MiniEDTA-free prote-
ase inhibitor (1 tablet; Roche) dissolved in 10ml of 100mM
potassium phosphate buffer pH 7.0. The lysis buffer was
deoxygenated by sparging with nitrogen for at least 1 h. The
cell samples were incubated in the anaerobic lysis buffer at
room temperature for 10–15min with shaking at 250 r.p.m.
and additional vortexing every 2–3min, and then centri-
fuged at 18 000 g for 20min at 4

C in sealed tubes outside
the workstation. The supernatants (soluble protein frac-
tions) were transferred into fresh tubes in the workstation.
Insoluble pellets were resuspended in the original volume of
the anaerobic lysis buffer and represented the insoluble pro-
tein fractions. Both protein fractions were analysed using
SDS-PAGE. Samples (20 µl) were loaded onto the gel (Any
kD Mini-PROTEAN TGX Precast Protein Gels, Mini-
Protean electrophoresis system, Bio-Rad). The gels were
stained using EZBlue Gel Staining Reagent (Sigma). Protein
concentrations were determined using the DC Protein
Assay (Bio-Rad). His-Bind Purification Kit (Novagen) and
Pierce Protein Refolding Kit (Fisher) were used according to
the manufacturers’ instructions.
Expression of fldZ was also scaled up to 1 l to prepare cell-
free extracts for enzymatic assays and biotransformations
by increasing the volumes of culture media and buffers. The
protein extracts were prepared in the lysis buffer described
above (final volume 7ml) except that the BugBuster Protein
Extraction Reagent was omitted and a cell disruptor at
40 kpsi (Constant Systems Ltd) was used to lyse the cells.
The protein extracts (about 5–6ml) were collected under a
flow of nitrogen gas in a 30ml universal bottle. The samples
were sealed immediately and transferred to the anaerobic
workstation, poured to 50ml plastic centrifuge tubes, sealed
and centrifuged at 18 000 g for 20min outside the worksta-
tion. The tubes were then transferred back to the worksta-
tion and the supernatants were collected for use in enzyme
assays. For long term storage, FldZ was drop frozen and
stored in liquid nitrogen.
Enoate reductase assay
2-Enoate reductase activity of E. coli protein extracts was
determined in a spectrophotometric assay, using anaerobic
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buffers and solutions that had been sparged with nitrogen
for at least 1 h. The reactions were set up in the anaerobic
workstation in gas-tight quartz cuvettes with silicone septa
(Hellma-Analytics) containing protein extracts (20 µl),
NADH (0.3 µmoles) in 50mM potassium phosphate buffer
pH 7.0 (880 µl). The cuvettes were pre-incubated at the
desired temperature for 5min in a temperature controlled
spectrophotometer (Agilent 8453) and the reactions were
started by injection of an anaerobic solution of substrate
(1 µmole) in the same buffer or tetrahydrofuran (100 µl), as
described in the text, using a gas-tight syringe. The initial
rate of NADH oxidation was determined by measuring the
decrease in absorbance at 340 nm using an extinction coeffi-
cient of 6220M 1 cm 1.
Biotransformations
Reduction of cinnamic acid and nitroalkenes was deter-
mined under anaerobic conditions in the workstation. All
buffers and solutions were made anaerobic by sparging with
nitrogen for at least 1 h prior to transfer into the worksta-
tion. Cinnamic acid reduction was measured by mixing the
substrate (30 µmoles) dissolved in 50mM potassium phos-
phate buffer pH 7.0 (6 ml), cell-free extract (20mg protein)
and NADH (36 µmoles) in 30ml screw top vials sealed with
silicone-PTFE caps. Reactions were shaken using an orbital
shaking platform (200 r.p.m.; Grant Bio POS-300) at 40

C.
After times stated in the text, samples (2ml) were taken,
and centrifuged (13 000 g, 1min) outside the workstation.
The supernatants were transferred into fresh 15ml polypro-
pylene centrifuge tubes (Falcon), acidified with 5 M HCl
(0.2ml) and extracted with diethyl ether (2.5ml) containing
an internal standard (tert-butylbenzene, 33 µmol). After
centrifugation (3000 g, 15min) the water-saturated organic
phase was dried by passing it through a 1ml pipette tip con-
taining anhydrous MgSO4. The dried sample (0.5ml) was
derivatised by adding methanol (0.1ml), followed by a few
drops (approx. 30 µl) of (trimethylsilyl)diazomethane solu-
tion (2.0 M in diethyl ether), until the mixture had a persis-
tent yellow colour, and incubated for 30min at room
temperature. Acetic acid (15 µl) was added to quench the
reaction. Samples were analysed by GCMS.
Nitroalkene biotransformations were performed in 30ml
screw top vials with silicone-PTFE caps. Each reaction con-
tained the substrate (8 µmoles) in anaerobic iso-octane
(4.8ml) mixed with anaerobic 50mM potassium phosphate
buffer pH 7.0 (7.2ml) containing protein crude extracts
(20mg), NADH (15 µmoles) and tert-butylbenzene (25 µl)
as an internal standard. Reactions were shaken in the anaer-
obic cabinet at 200 r.p.m. at 40

C for 24–72 h. Samples were
taken from the organic phase, which separated readily by
allowing to stand. Samples were analysed by liquid
chromatography.
Analytical methods
Cinnamic acid and phenylpropanoic acid samples were ana-
lysed by GC-MS (Agilent 7890A) equipped with a HP5-MS
capillary column (0.25mm by 30m by 1 µm; Agilent) and
an inert mass selective detector (Agilent 5975C) with a
quadrupole mass analyser. Ultra-pure helium was used as
carrier gas at 1.2ml min 1 flowrate. Samples (1 µl, split ratio
100 : 1) were injected at 300

C. The initial oven temperature
was held at 45

C for 5min, then increased at 20

C min 1
to 300

C, and held for 10min. Retention times of the inter-
nal standard tert-butylbenzene, substrates and products
were compared to the retention times of authentic stand-
ards. Concentrations were calculated from calibration
curves.
Samples of nitroalkenes (15 µl) and their reduction products
in the iso-octane phase were analysed by HPLC (Agilent)
using a Chiralcel OJ column (4.6mm250mm ID) and
hexane:isopropyl alcohol (9 : 1) as a mobile phase at 1ml
min 1 flowrate. Sample components were detected at
254 nm. Substrates and products were identified and quanti-
fied by comparing the retention times with authentic stand-
ards of racemic nitroalkanes, relative to the internal
standard, tert-butylbenzene.
GenBank accession numbers
The partial sequence of C. sporogenes genome containing
fldZ was deposited in the GenBank as KT897281. The FldZ
reductase amino acid sequence was deposited as
AMQ78444. The sequence of plasmid pET20b(+):CsfldZ
containing the C. sporogenes fldZ gene codon optimised for
expression in E. coli was deposited as KY369208.
RESULTS
Identification of 2-enoate reductase in
C. sporogenes DSM 795
C. sporogenes DSM 795 contains an NADH-dependent
2-enoate reductase that belongs to the family of clostridial
2-enoate reductases containing FAD and an iron-sulphur
centre [14]. The enzyme was proposed to be responsible
for reduction of cinnamic acid to 3-phenylpropionic acid
in the Stickland reaction [11]. This unusual metabolic
pathway allows proteolytic clostridia to obtain carbon and
energy for growth by coupling together the oxidation and
reduction of pairs of amino acids. Although crude cell-free
extracts of DSM 795 catalyse the reduction of nitroolefins,
(E)-1-nitro-2-phenylpropene and (E)-2-nitro-1-phenylpro-
pene, it has not been possible to purify the enzyme directly
from C. sporogenes [20]. However, the structural similari-
ties between cinnamate and nitroolefins and the known
broad substrate range of all types of carbon-carbon double
bond reductases [7, 23] may suggest that both can be
reduced by the same enzyme. Therefore, we used a bioin-
formatics approach to search for 2-enoate reductase homo-
logues in C. sporogenes. The genome sequence of
C. sporogenes DSM 795 was not available when this work
was initiated, so the genomes of closely related proteolytic
strains Clostridium botulinum strain Hall A ATCC 3502
[24, 25] and C. sporogenes ATCC 15579 were analysed for
the presence of genes encoding clostridial 2-enoate reduc-
tases, based on the sequences of previously identified
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enzymes in M. thermoacetica and C. tyrobutyricum [18].
One open reading frame in each genome, the fldZ gene in
C. botulinum and CLOSPO_02780 in C. sporogenes ATCC
15579, showed significant homology to the M. thermoace-
tica and C. tyrobutyricum genes. PCR primers were
designed to highly conserved regions located upstream and
downstream of the consensus sequences of both genes (pri-
mers PM003 and PM008). These primers were used in
PCR on C. sporogenes DSM 795 genomic DNA. The reac-
tions yielded a 3.3 kb product of the expected size which
was cloned into the pJET1.2 vector and sequenced. The
sequence (Supplementary information 1; deposited in Gen-
Bank as KT897281) contained an open reading frame
encoding 665 amino acids which shared 98% identity and
99% similarity to CLOSPO_02780 from C. sporogenes
ATCC 1559, and 99% identity and 99% similarity to FldZ
from C. botulinum str. Hall A ATCC 3502. The molecular
weight of the enzyme subunit and its predicted amino acid
composition were identical to enzymes purified from
C. kluyveri and C. sporogenes and annotated as 2-butenoate
and cinnamate reductases, respectively [11, 14, 15]. The
predicted amino acid sequence of the DSM 795 FldZ
showed that the N-terminal domain is similar to the classi-
cal OYE-like carbon-carbon double bond reductases (con-
served NemA domain) and forms a FMN binding motif
and substrate/catalytic site (Fig. S1, available in the online
Supplementary Material). Clostridial 2-enoate reductases
also contain four conserved cysteine residues responsible
for interaction with the iron-sulphur (Fe-S) cluster. The C-
terminal part of the DSM 795 FldZ, which does not share
any homology with OYE-like reductases, contains a small
NADH binding domain within a larger FAD binding
domain, a characteristic feature of clostridial 2-enoate
reductases. Phylogenetic analysis revealed that the DSM
795 FldZ clusters most closely with the FldZ of C. botuli-
num str. Hall A ATCC 3502 (Fig. 1; yellow box) and then
with 2-enoate reductases from other species (C. tyrobutyri-
cum, C. kluyveri and M. thermoacetica). OYE-like reduc-
tases (red box) are much smaller proteins containing
329–402 amino acids, and these enzymes cluster separately.
This suggests that DSM 795 FldZ is a member of the clos-
tridial 2-enoate reductase family, with close similarity to
the known enzymes. Although it shares a similar domain
with OYEs, the enzyme is much less closely related to
these enzymes than the clostridial enzymes, since it is
much larger and contains both iron sulphur and FAD
binding sites, in addition to the FMN binding site.
Heterologous expression of the DSM 795 fldZ gene
in E. coli
The C. sporogenes 2-enoate reductase gene was overex-
pressed in E. coli BL21(DE3)pLysS using the IPTG-induc-
ible pET vector system. It has been suggested that the
previous unsuccessful attempt to express 2-enoate reduc-
tase from C. tyrobutyricum was due to the low GC content
of the DNA [18]. Therefore, the fldZ gene was optimised
for expression in E. coli using the GENEius sequence adap-
tation tool and the modified fldZ gene sequence was
synthesised de novo. Initial expression of the reductase
using the pET20b(+):CsfldZ construct using aerobically
grown E. coli resulted in expression of insoluble protein
only. Activity assays with cinnamic acid as the substrate
conducted under anaerobic conditions showed that the
recombinant protein was inactive (data not shown). There-
fore, we investigated the effect of fldZ expression in E. coli
grown under strictly anaerobic conditions. This resulted in
the formation of mixture of soluble and insoluble FldZ
with the expected size, about 73 kDa (data not shown).
Furthermore, cinnamate reductase activity could be
detected, with a specific activity of 378±22 nmol min 1
mg 1. No activity was detected in a control strain harbour-
ing the empty expression plasmid.
In an attempt to purify the reductase, additional constructs
were generated encoding FldZ tagged with the N-terminal
6xHis-tag, T7-tag, GST-tag, Strep-tag and S-tag as well as
FldZ tagged on the C-terminus with 6xHis-tag (Supplemen-
tary information 3, Fig. S2). However, only the reductase
with the N-terminal His-tag was expressed as a soluble pro-
tein and showed detectable activity in the cinnamic acid
reduction assay. The specific activity was only 174±8 nmol
min 1 mg 1, 46% of the activity compared to the untagged
enzyme. Activity was lost when the enzyme was purified
using Ni-NTA resin (Novagen), although the enzyme was
almost completely pure judging by the SDS-PAGE analysis.
Addition of cofactors such as FAD (10 µM) and FMN
(10 µM), or reducing agents such as dithiothreitol (10mM)
or tris(hydroxypropyl)phosphine (1mM) to the buffers did
not result in recovery of enzymatic activity. Attempts to
refold the reductase using Pierce Protein Refolding Kit
under anaerobic conditions were also unsuccessful. Since
protein extracts of E. coli BL21(DE3)pLysS expressing the
empty plasmid did not show cinnamate reductase activity,
the properties of FldZ were further characterised by testing
the enzymatic activity of unpurified protein extracts of
E. coli expressing the untagged protein.
Optimisation of the DSM 795 FldZ reductase
activity
Before investigating biotransformations, the conditions for
optimal activity of FldZ were determined using an
NADH-dependent spectrophotometric assay using cin-
namic acid as the substrate. The highest reaction rate was
observed at 40–45

C (Fig. 2a). Higher temperatures
caused a gradual decrease in FldZ activity, and the enzyme
was completely inactive at 60

C. The optimum pH for
activity was between 7.0–7.5 (Fig. 2b). Therefore, further
experiments were undertaken using 50mM phosphate
buffer pH 7.0 at 40

C. The reduction of cinnamic acid to
3-phenylpropionic acid was measured directly by GC-MS,
using NADH as the hydrogen donor, under anaerobic
conditions. Cinnamic acid was reduced to 3-phenylpro-
pionic acid at an initial rate of 1.35 µmol min 1 mg 1
(Fig. 3). The rate decreased after 2 h, but continued slowly
until the yield of 3-phenylpropionic acid was almost 100%
after 24 h. No product formation was observed in control
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experiments with E. coli expressing empty pET20b(+). The
effect of oxygen on FldZ activity was investigated by
exposing samples of protein extracts to air for time inter-
vals between 15min and 3 h, keeping the samples on ice
throughout the exposure time. The protein extracts were
then tested for cinnamic acid reduction using NADH as
the electron donor under anaerobic conditions at 40

C,
measuring substrate and product concentrations after 2 h
by GC-MS (Fig. 4). FldZ lost 57% of the activity after 2 h
of exposure to air, and activity could not be restored by
reintroduction of anaerobic conditions. When the enzyme
was incubated under anaerobic conditions at 4

C, there
was no loss of activity, indicating that the DSM 795 FldZ
enzyme was stable when stored on ice. Therefore, the
enzyme is inactivated by exposure to air, although at a rel-
atively slow rate.
Substrate range of the DSM 795 FldZ
FldZ was tested for oxidation of NADH in the presence of
unsaturated aromatic and aliphatic carboxylic acids using
the spectrophotometric assay. Reactions containing protein
extracts of E. coli expressing the empty pET20b(+) were
used as controls to subtract the background activity of
native E. coli oxidoreductases. Because of poor water solubil-
ity of some chemicals tested, stock solutions of all the sub-
strates were prepared in tetrahydrofuran (THF). The rate of
cinnamate-dependent NADH oxidation was similar in the
presence and absence of 10% THF, indicating that THF did
not inhibit FldZ. The enzyme showed a narrow substrate
range for reduction of 2-enoates. The highest rate of NADH
oxidation was observed in the presence of cinnamic acid
(Table 1). The presence of methyl groups in the alpha or
beta positions drastically decreased the activity to about 1%.
p-Coumaric acid was a relatively good substrate (43% activ-
ity when compared to cinnamic acid), but there was almost
no activity when the aromatic ring was further substituted
(caffeic acid and indoleacrylic acid). FldZ did not accept ali-
phatic enoates at all, suggesting that the aromatic ring plays
a crucial role in the interaction between the enzyme and the
substrate.
Fig. 1. Evolutionary relationships of various carbon-carbon double bond reductases. The evolutionary history was inferred using the
Neighbour-Joining method. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test
(1000 replicates) is shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evo-
lutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Poisson correction method
and are in the units of the number of amino acid substitutions per site. Evolutionary analyses were conducted in MEGA6 [41]. Yellow: 2-
enoate reductases from proteolytic clostridia; green: previously characterized 2-enoate reductases from non-proteolytic organisms;
red: classical OYE-like reductases. Sequences used to generate the tree were: NADH:flavin oxidoreductase Dickeya dadantii (C6C4J2);
reductase Clostridium novyi (WP_011722529); fldZ reductase C. botulinum str. A (WP_011986666); 2-enoate reductase Clostridium aceto-
butylicum (WP_010966642); 2-enoate reductase M. thermoacetica (CAA76082); 2-enoate reductase C. kluyveri (CAA76083); 2-enoate
reductase C. tyrobutyricum (CAA71086); YqjM Bacillus subtilis (P54550); hypothetical protein CLOSPO_03444 C. sporogenes ATCC 15579
(EDU37275); NADH oxidase Peptostreptococcus anaerobius (WP_002842930); NADH:flavin oxidoreductase (NCR) Zymomonas mobilis
(WP_012817614); PETNR Enterobacter cloacae (3P7Y_A); Oye2p Saccharomyces cerevisiae (EDN62417); OPR3 Lycopersicon esculentum
(NP_001233873); OPR1 Lycopersicon esculentum (NP_001234781); 2,4-dienoyl-CoA reductase Saccharomyces cerevisiae (CAA55506)
and enoyl reductase Saccharomyces cerevisiae (NP_010269).
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Cell-free extracts of E. coli expressing fldZ were also used for
reduction of (E)-1-nitro-2-phenylpropene and (E)-2-nitro-
1-phenylpropene, in a biphasic biotransformation contain-
ing iso-octane to deliver the water-insoluble substrates. The
samples were incubated at 40

C and the yield and enantio-
meric excess of reactions were determined by chiral HPLC
(Table 2). Although extracts of the E. coli host containing
the empty vector did not reduce cinnamic acid, there was
detectable nitroalkene reductase activity. Thus, E. coli
extracts containing the empty cloning vector reduced both
(E)-1-nitro-2-phenylpropene and (E)-1-phenyl-2-nitropro-
pene with poor yields (7 and 17% after 72 h, respectively)
and very modest enantiomeric excess (51 and 20%). How-
ever, the expression of fldZ significantly improved biotrans-
formations yields. FldZ showed >99% enantioselectivity for
reduction of (E)-1-nitro-2-phenylpropene, which was
reduced in 90% yield of (R)-1-nitro-2-phenylpropane. (E)-
2-Nitro-1-phenylpropene was reduced to (S)-2-nitro-1-phe-
nylpropane in 56% yield, but with only 16–17% ee. It is
possible that the competing background nitroalkene reduc-
tase activity in the host may have contributed to the overall
poor enantioselectivity. Therefore, further work is needed
either to purify the enzyme by alternative strategies (e.g.
conventional column chromatography) or to inactivate the
interfering reductases in the expression host by one of many
strategies available for generation of gene knock-outs in
E. coli. Potential candidates include known E. coli reduc-
tases, such as NEM, which catalyses the reduction of unsat-
urated compounds, such as 1-nitrocyclohexene [26] or
nitroreductases, which can also reduce carbon-carbon
double bonds [27]. Nevertheless, there was no significant
interference with the DSM 795 FldZ-catalysed reduction of
(E)-1-nitro-2-phenylpropene, which was reduced with
almost perfect enantioselectivity.
DISCUSSION
Since the 1990s, carbon-carbon double bond reductases
have attracted significant attention as biocatalysts for stereo-
selective hydrogenation of activated alkenes. Although the
first reports on stereospecific reductions using Clostridium
spp. were published in the 1970s [13], clostridial 2-enoate
reductases have not been fully assessed for synthetically use-
ful asymmetric hydrogenation. One of the key barriers is a
widely held perception that it is difficult to grow and handle
clostridia [10], despite their widespread use for biobutanol
production at scale [28]. For this reason, we expressed the
cloned DSM 795 fldZ gene in E. coli, to facilitate future
exploitation of this unusual 2-enoate reductase.
Fig. 2. Temperature (a) and pH (b) profiles of FldZ activity in the 2-
enoate reductase spectrophotometric assay. Cell-free extracts (20mg)
of E. coli expressing fldZ were used to oxidise NADH under anaerobic
conditions in the presence of cinnamic acid. The reaction rate was
determined from the decrease in absorbance at 340 nm. The effect of
pH was tested in 50mM potassium phosphate solutions adjusted to a
range of pH values, with the lowest being outside the buffering range
of 5.8–8.0. Error bars represent standard deviations of three indepen-
dent experiments.
Fig. 3. Anaerobic biotransformations of cinnamic acid using cell-free
protein extracts of E. coli expressing fldZ. Reaction mixtures in 50mM
phosphate buffer (6ml) contained cinnamic acid (30 µmoles) and
NADH (36 µmol) as the electron donor. Error bars represent standard
deviations of three independent experiments. Conversion of cinnamic
acid (.) and formation of 3-phenylpropionic acid (&) were determined
by derivatization to methyl esters and GC-MS.
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2-Enoate reductase genes from the non-proteolytic strains
C. acetobutylicum [5] and M. thermoacetica [18] have been
expressed in E. coli, albeit without characterisation of either
of the recombinant enzymes produced. Our report is the
first example of successful production and isolation of an
active recombinant 2-enoate reductase from a proteolytic
Clostridium and its use for industrially relevant biotransfor-
mations. There are significant differences in codon usage
between E. coli and clostridia [18], so expression studies
were undertaken with a synthetic fldZ gene codon optimised
for expression in E. coli. Although aerobic expression was
unsuccessful, active FldZ could be isolated when the E. coli
host was grown anaerobically. It should be noted that,
unlike C. sporogenes, E. coli is a facultative anaerobe, so it
may also be possible to grow the host aerobically and then
switch to anaerobic conditions immediately before induc-
tion of fldZ. Similar approaches have been used previously
to express oxygen sensitive systems in E. coli [29, 30]. When
the aeration is stopped, anaerobic conditions develop rap-
idly, due to the rapid rate of oxygen consumption by
actively growing cells, enabling expression of the active, oxy-
gen sensitive system. In future work, this strategy can be
investigated as a means to simplify FldZ production at scale.
The DSM 795 FldZ enzyme was stable in vitro under anaer-
obic conditions for at least 3 h without losing activity, but
was irreversibly inhibited after exposure to air. This is a sig-
nificant difference when compared with classical OYEs,
which can be overexpressed under aerobic conditions and
used for anaerobic biotransformations after deoxygenation
[31]. Moreover, some OYEs are still active under aerobic
conditions, although the presence of oxygen can change the
enantiopurity of the reaction products [32]. The optimal
temperature and pH of recombinant DSM 795 FldZ were
similar to those reported previously using 2-enoate reduc-
tase isolated directly from C. sporogenes [11], but differ sig-
nificantly from those reported for 2-enoate reductases from
Fig. 4. Inactivation of FldZ by air. Anaerobic biotransformations of cin-
namic acid using cell-free protein extracts of E. coli expressing fldZ.
Reaction mixtures in 50mM phosphate buffer (6ml) contained cin-
namic acid (30 µmoles) and NADH (36 µmoles) as the electron donor.
Error bars represent standard deviations of three independent experi-
ments. Protein cell-free extracts were exposed to air, then degassed
by sparging with nitrogen and used for reduction of cinnamic acid
under anaerobic conditions. The yields of the biotransformations were
normalized to the yield of the control sample, FldZ not exposed to air.
Protein extracts exposed (&) and not exposed (.) to air.
Table 1. Substrate range of the DSM 795 FldZ 2-enoate reductase. Cell-free protein extracts of E. coli expressing fldZ were used to oxidise NADH in
the presence of unsaturated carboxylic acids dissolved in THF
The enzyme activity was determined by measuring decrease in the absorbance at 340 nm. Protein extracts of E. coli expressing the empty expression
vector were used to determine and subtract the background activities for each substrate of native E. coli oxidoreductases. Errors represent standard
deviations of three independent experiments. ND, not detected.
Substrate Structure Activity (nmol min 1 mg 1) Relative activity
cinnamic acid 498±39 100%
a-methyl-cinnamic acid <3±0.1 <0.7%
b-methyl-cinnamic acid 7.8±0.3 1.6%
p-coumaric acid 218.4±21 43.3%
caffeic acid 4.2±0.2 0.8%
3-indoleacrylic acid <2.4±0.3 <0.5%
crotonic acid ND –
2,3-dimethylacrylic acid ND –
3,3-dimethylacrylic acid ND –
2-methyl-2-pentenoic acid ND –
sorbic acid ND –
Mordaka et al., Microbiology
8
Downloaded from www.microbiologyresearch.org by
IP:  128.243.2.175
On: Wed, 17 Jan 2018 15:11:09
other anaerobes [14], showing a diversity in this class of
enzymes.
Previously, 2-enoate reductases were purified directly from
Clostridium spp. and other strains using a multi-step protein
chromatography method [14, 18, 19], which was laborious
and required specialised equipment for maintaining anaero-
bic conditions during the course of purification. To attempt
easier purification, we decided to produce recombinant
FldZ that incorporated affinity tags. In the past OYEs have
been successfully overexpressed and purified as His-tagged
proteins [33–35]. By contrast, our attempts to tag and purify
FldZ using affinity chromatography techniques were unsuc-
cessful. This may reflect the complexity of clostridial 2-
enoate reductases, and their multiple cofactor content.
Nevertheless, an inability to purify the enzyme would not
prevent its exploitation in the future, since it is simpler to
use whole cells expressing the enzyme, to solve problems
with expensive cofactor recycling. However, the background
activity of E. coli enzymes may interfere with stereospecific-
ity and enantioselectivity of the reaction of interest. This
should be carefully assessed for each substrate tested, and, if
needed, the interfering reductases in the expression host can
be inactivated.
The key advantage of using clostridial 2-enoate reductases is
their ability to reduce less activated substrates containing
carbon-carbon double bonds conjugated with carboxylic
acid groups [13, 14, 18], which are often not reduced by
classical OYEs [8]. We confirmed that the DSM 795 FldZ
can reduce 2-enoates, although with a narrower substrate
range than the enzymes from non-proteolytic clostridia and
other genera. Thus, FldZ reduced cinnamic acid and p-cou-
maric acid at the highest rates, whereas a- and b-methyl
cinnamic acid, caffeic acid and 3-indoleacrylic acid were
extremely poor substrates, and aliphatic 2-enoates were not
reduced at all. Further work is needed to test the scope
to express other clostridial 2-enoate reductases in anaerobi-
cally-grown E. coli, to provide access to a broader range of
alkanoates.
The DSM 795 FldZ enzyme was also used successfully to
reduce prochiral nitroalkenes. The b,b-disubstituted nitro-
alkene, (E)-1-nitro-2-phenylpropene, was reduced to (R)-1-
nitro-2-phenylpropane with high yields and excellent ee.
The stereoselectivity of FldZ is similar to carbon-carbon
double bond reductases such as yeast OYE1-3 [36], OPR1
from tomato [37], and KYE1 and YersER [35], but is oppo-
site to PETNR [38], OPR3, YqjM [37] and NCR-reductase
from Zymomonas mobilis [36]. The unpurified FldZ showed
higher enantioselectivity than purified OYE1-3 from yeast
and comparable enantioselectivity and activity to OPR1,
KYE1 and YersER. By contrast, the a,b-disubstituted nitro-
alkene, (E)-2-nitro-1-phenylpropene, was reduced to
(S)-2-nitro-1-phenylpropane with moderate yield and poor
enantioselectivity. However, the yield of the product (56%)
was significantly improved when compared to the reduction
using C. sporogenes DSM 795 protein extracts (yield 20%)
under similar reaction conditions [20].
C. sporogenes may contain enzymes other than FldZ that
also catalyse nitroalkene reduction. Preliminary attempts to
purify the nitroalkene reductase directly from C. sporogenes
by conventional chromatography indicated the presence of
more than one enzyme reducing (E)-2-nitro-1-phenylpro-
pene (unpublished results). Furthermore, the analysis of
genome sequences of C. botulinum ATCC 3502, C. sporo-
genes ATCC 15579 and recently published genomes of
C. sporogenes NCIMB 10696 [39] and C. sporogenes DSM
795 [40] revealed the presence of an open reading frame
showing features characteristic for OYE-like reductases
(Fig. 1; CLOSPO_03444). This would be a perfect candidate
for the second enzymatic activity, since homologous flavin
containing reductases such as PETNR, KYE1, YersER and
NRSal were found to reduce a,b-disubstituted nitroalkenes
[27, 35, 38].
To conclude, we have shown that the C. sporogenes DSM
795 FldZ 2-enoate reductase has potential as an industrial
biocatalyst due to its ability to catalyse the NADH-depen-
dent reduction of a variety of activated alkenes in a stereose-
lective manner. It is an efficient catalyst for the reduction of
Table 2. Anaerobic reduction of phenylnitropropenes using DSM 795 FldZ reductase
Biphasic reactions contained protein cell-free extracts of E. coli expressing fldZ and NADH (15 µmoles) in 50mM potassium phosphate buffer (7.2ml)
and the substrate (8 µmoles) dissolved in iso-octane (4.8ml). Control experiments contained cell-free protein extracts of E. coli transformed with the
empty expression vector. Reaction yields and enantiomeric excess were determined by chiral HPLC. Errors represent standard errors of mean of
three independent biotransformations.
Substrate Strain Yield (%) ee (%)
24 h 48 h 72 h 24 h 48 h 72 h
(E) 1-nitro-2-phenylpropene
fldZ 72.0±4.5 81.0±3.3 90.1±3.8 >99 (R) >99 (R) >99 (R)
pET20b(+) 6.3±0.1 7.5±0.2 7.7±0.4 54.8±4.5 (R) 52.6±0.6 (R) 51.4±9.1 (R)
(E) 2-nitro-1-phenylpropene
fldZ 35.2±0.3 48.9±0.4 56.0±1.9 17.0±0.5 (S) 16.1±1.6 (S) 16.9±0.2 (S)
pET20b(+) 10.2±4.2 17.2±2.8 17.0±0.6 16.8±5.5 (S) 17.2±1.6 (S) 20.3±2.3 (S)
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aromatic 2-enoates as well as b,b- and a,b-disubstituted
nitroalkenes.
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